RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
ANNALS OF ONCOLOGY
Collezione AO Cuneo

Items : 10

Maintenance versus discontinuation of androgen deprivation therapy during docetaxel administration with a continuous or an intermittent schedule in metastatic, castration resistant, prostate cancer patients: A multicenter randomized phase III study of the Piemonte Oncology Network in Annals of Oncology

2020
ASL Biella
ASL Città di Torino
ASL Asti
AO Cuneo
ASL Cuneo 2
AOU Città della Salute di Torino

Fea E; Buttigliero C; Montagnani F; Comandone A; Gennari A; Tucci M; Chiappino I; Canton OD; Masini C; Sacco† C; Amoroso D; Sirotova Z; Ciccone G; Valcamonico F; Vanella P; Ortega C; Prati V; Bianchi S; Mosca A; Berruti A;

Correlation between values of specific biomarkers and outcome in metastatic colorectal cancer patients treated with regorafenib in Annals of Oncology

2019
AO Cuneo

Ricci V; Falletta A; Granetto C; Paccagnella M; Abbona A; Fea E; Fabozzi T; Lo Nigro C; Merlano M;

Correlation between values of specific biomarkers and outcome in metastatic colorectal cancer patients treated with regorafenib in Annals of Oncology

2019
AO Cuneo
AOU Città della Salute di Torino

Ricci V; Falletta A; Granetto C; Paccagnella M; Abbona A; Fea E; Fabozzi T; Lo Nigro C; Merlano M; Zucchelli G; Marmorino F; Rossini D; Aprile G; Casagrande M; Lonardi S; Murgioni S; Dell'Aquila E; Tomasello G; Moretto R; Antoniotti C; Borelli B; Urbano F; Ronzoni M; Zaniboni A; Manglaviti S; Buonadonna A; Ritorto G; Masi G; Allegrini G; et alii...

Phase II study of NAB-paclitaxel in sensitive and refractory relapsed SCLC (NABSTER TRIAL) in Annals of Oncology

2018
AO Cuneo

Gelsomino F; Tiseo M; Barbieri F; Riccardi F; Cavanna L; Frassoldati A; Delmonte A; Longo L; Dazzi C; Cinieri S; Colantonio I; Tognetto M; Baldari D; Tofani L; Ardizzoni A;

Correlation between the prognostic value of tumor-infiltrating lymphocytes (TILS) and sidedness in colorectal cancer (CC) patients (pts) in Annals of Oncology

2017
AO Cuneo

Granetto C; Ricci V; Fea E; Vivenza D; Lo Nigro C; Fortunato M; Comino A; Merlano M;

How to enhance nonprofit clinical research in a General Hospital in Annals of Oncology

2016
AO Cuneo

Violante S; Merlano MC; Lattanzio L; Giurlanda F; Curcio P;

Tumor-infiltrating lymphocytes (TILs) density as prognostic determinant in stage II colorectal cancer in Annals of Oncology

2016
AO Cuneo

Ricci V; Comino A; Vivenza D; Granetto C; Lo Nigro C; Ferrero M; Merlano MC;

Retrospective evaluation of ADCC activity and cetuximab response in KRAS wild-type metastatic colorectal cancer patients (mCRC) in Annals of Oncology

2015
AO Cuneo

Ricci V; Vivenza D; Monteverde M; Strola G; Granetto C; Lo Nigro C; Merlano MC;

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer in Annals of Oncology

2014
ASL Biella
AO Cuneo
AOU Città della Salute di Torino
ASL Cuneo 2

Bajetta E; Floriani I; Di Bartolomeo M; Labianca R; Falcone A; Di Costanzo F; Comella G; Amadori D; Pinto C; Carlomagno C; Nitti D; Daniele B; Mini E; Poli D; Santoro A; Mosconi S; Casaretti R; Boni C; Pinotti G; Bidoli P; Landi L; Rosati G; Ravaioli A; Cantore M; Di Fabio F; Aitini E; Marchet A; Rulli E; Cropalato Di Tullio M; et alii...

NK/T-cell lymphomas 'nasal type': An Italian multicentric retrospective survey in Annals of Oncology

2006
AO Cuneo

Pagano L; Gallamini A; Trapè G; Fianchi L; Mattei D; Todeschini G; Spadea A; Cinieri S; Iannitto E; Martelli M; Nosari A; Di Bona E; Tosti ME; Petti MC; Falcucci P; Montanaro M; Pulsoni A; Larocca LM; Leone G;